VC-backed Nivalis files for IPO
Boulder, Colorado-based Nivalis Therapeutics, a developer of drugs for patients with cystic fibrosis, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Nivalis plans on trading the stock on the NASDAQ under the ticker symbol "NVLS." Cowen and Company and Stifel are serving as lead underwriters. The company's backers include Apple Tree Partners, Deerfield, RA Capital, Rock Springs Capital and Wellington Management.
14 May 2015•3 mins read
